Bayer, DE000BAY0017

The Aspirin Cardio from Bayer AG - low-dose classic for long-term heart therapy

Published on 06/24/2026 at 09:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The Aspirin Cardio from Bayer AG delivers 100 mg enteric-coated acetylsalicylic acid per tablet and is designed for long-term cardiovascular prevention in adults. This classic keeps the Bayer shares in focus for many conservative investors (ISIN DE000BAY0017).

Bayer, DE000BAY0017, Illustration mit AI erstellt.
Bayer, DE000BAY0017, Illustration mit AI erstellt.

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-24, 09:53. Details in the imprint.

When you shake a blister strip of Aspirin Cardio from Bayer AG, the small white tablets rattle quietly like tiny marbles, a familiar sound in many medicine cabinets where this low-dose classic has sat for years as daily heart protection.

What Aspirin Cardio is made for

Aspirin Cardio is a low-dose formulation of acetylsalicylic acid (ASA) developed for long-term prevention of cardiovascular events such as heart attack and stroke in adults with increased risk. Official Bayer product information

The tablets typically contain 100 mg ASA and feature an enteric coating designed to dissolve in the intestine rather than the stomach, which many cardiologists appreciate when they think about gastric tolerance in older patients.

How the tablet behaves in daily use

The film-coated tablets are small, flat and smooth, so they slide off a fingertip easily when you push them from the blister, a detail that matters when hands are not as steady as they used to be.

According to cardiologist Professor Jürgen Scholze, who has commented on ASA therapy in several clinical reviews, consistent daily intake of low-dose ASA remains a cornerstone in secondary prevention of myocardial infarction, provided bleeding risk is carefully assessed beforehand. ESC cardiology practice article

Go deeper

Background on Bayer AG and its healthcare portfolio

From classic brands like Aspirin Cardio to modern oncology drugs, Bayer covers a broad spectrum of therapies that continue to shape the discussion among healthcare investors.

Why Bayer keeps this classic narrow

Bayer positions Aspirin Cardio strictly as a prescription medicine in many markets, underlining that decisions on initiation or discontinuation must lie with physicians who can weigh thrombotic versus bleeding risks for each individual.

CEO Bill Anderson has recently stressed in interviews that established cardiovascular brands still form an important, steady pillar of the pharma division, even as Bayer pushes into newer areas like cell and gene therapy. Bayer annual report pharmaceuticals section

Indications, limits and safety

Aspirin Cardio is typically indicated for secondary prevention after myocardial infarction, after certain types of stroke, or in patients with chronic coronary artery disease, but it is not a casual "just in case" pill for healthy individuals.

Because ASA inhibits platelet aggregation, bleeding risks rise, so treatment is usually avoided in patients with active ulcers, known bleeding disorders, or a history of ASA-induced asthma, unless a specialist explicitly decides otherwise.

Packaging, dosage and routine

In pharmacies the product often comes in packs of 28, 56 or 98 tablets, tuned to monthly or quarterly prescriptions so that patients build a simple habit: one tablet daily, always at the same time.

Many users describe a quiet relief in knowing that the once-daily routine is as simple as a single small tablet with a sip of water, no complicated titration or frequent dose adjustments required once the regimen is set.

Where it is available and for whom

Aspirin Cardio is widely available in European pharmacies, often behind the counter with a prescription requirement, and similar low-dose ASA cardiology products are marketed by Bayer in other regions under related brand names.

The target group is clearly adults with diagnosed cardiovascular disease or a documented elevated risk, not young, healthy users looking for occasional pain relief, which Bayer addresses instead with its classic over-the-counter Aspirin pain tablets.

Company context and shares

All told, Aspirin Cardio may be a quiet workhorse in Bayer's portfolio, but it sits at the intersection of brand heritage and modern cardiology, anchoring the healthcare story that investors still watch closely. Bayer shares (ISIN DE000BAY0017) trade on Xetra in euros as part of Germany's DAX index.

Key facts on Aspirin Cardio

  • Product: Aspirin Cardio
  • Manufacturer: Bayer AG
  • Category: Classic prescription cardiovascular drug
  • Launch: Introduced in the 1990s as low-dose ASA variant for cardiology
  • RRP / Price: Varies by market and pack size, typically a few euros per month in Germany
  • Availability: Pharmacy-only, prescription requirement in many European markets
  • Target group: Adults with increased cardiovascular risk under medical supervision
  • Highlight / USP: Low-dose, enteric-coated ASA tailored for long-term heart and stroke prevention

Aspirin Cardio in German pharmacies

If you prefer to order online instead of visiting a local pharmacy, check whether your pharmacy partner offers prescription processing for Aspirin Cardio and follow the legal requirements in your country.

Aspirin Cardio on Amazon

Affiliate link: ad-hoc-news.de earns a commission when you buy via this link. The price for you does not change.

Find more perspectives on Aspirin Cardio

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE000BAY0017 | BAYER | boerse | 69616791 | bgmi